Cargando…

Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials

BACKGROUND: For treatment of patients diagnosed with schizophrenia, comparative long-term effectiveness of antipsychotic drugs to reduce relapses when minimising adverse effects is of clinical interest, hence prompting this review. AIMS: To evaluate the comparative long-term effectiveness of antipsy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Ying Jiao, Lin, Liang, Teng, Monica, Khoo, Ai Leng, Soh, Lay Beng, Furukawa, Toshiaki A., Baldessarini, Ross J., Lim, Boon Peng, Sim, Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal College of Psychiatrists 2016
Materias:	Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995551/ https://www.ncbi.nlm.nih.gov/pubmed/27703755 http://dx.doi.org/10.1192/bjpo.bp.115.002576

Ejemplares similares

Suicidal Risks in Reports of Long-Term Treatment Trials for Major Depressive Disorder
por: Baldessarini, Ross J., et al.
Publicado: (2015)

Second International Consensus Study of Antipsychotic Dosing (ICSAD-2)
por: McAdam, Matthew KT, et al.
Publicado: (2023)

Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II
por: Baldessarini, Ross J., et al.
Publicado: (2016)

Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium
por: Vázquez, Gustavo H., et al.
Publicado: (2021)

Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
por: Pompili, Maurizio, et al.
Publicado: (2016)

Pharmacological Approaches for Treatment-resistant Bipolar Disorder
por: Poon, Shi Hui, et al.
Publicado: (2015)

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
por: Tajika, Aran, et al.
Publicado: (2023)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Second Generation Antipsychotics Improve Sexual Dysfunction in Schizophrenia: A Randomised Controlled Trial
por: Mahmoud, Ahmed, et al.
Publicado: (2011)

Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics
por: Ventriglio, Antonio, et al.
Publicado: (2019)

Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)
por: Moncrieff, Joanna, et al.
Publicado: (2019)

Risk factors for osteoporosis in chronic schizophrenia on long-term treatment with antipsychotics: a cross-sectional study
por: Liu, Furu, et al.
Publicado: (2023)

Bone Density in Chronic Schizophrenia with Long-Term Antipsychotic Treatment: Preliminary Study
por: Lee, Tae-Young, et al.
Publicado: (2010)

Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia
por: Shrivastava, Amresh, et al.
Publicado: (2012)

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
por: O’Day, Ken, et al.
Publicado: (2013)

Correction: Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)
Publicado: (2020)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

Comparative effectiveness of antipsychotic drugs in schizophrenia
por: Stroup, T. Scott, et al.
Publicado: (2000)

The heterogeneity of antipsychotic response in the treatment of schizophrenia
por: Case, M., et al.
Publicado: (2011)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
por: Wu, Haishan, et al.
Publicado: (2013)

Antipsychotic agents: efficacy and safety in schizophrenia
por: de Araújo, Arão Nogueira, et al.
Publicado: (2012)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
por: Kamei, Hiroyuki
Publicado: (2022)

Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
por: Jeong, Seong Hoon, et al.
Publicado: (2018)

PM441. Long term atypical antipsychotic treatment improves cognitive performance in schizophrenia but not surpassing conventional antipsychotic drugs effects.
por: Vera, Gabriel Selva, et al.
Publicado: (2016)

Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials
por: Sim, Kang, et al.
Publicado: (2015)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Predictors of switching antipsychotic medications in the treatment of schizophrenia
por: Nyhuis, Allen W, et al.
Publicado: (2010)

Developments in antipsychotic therapy with regard to hypotheses for schizophrenia
por: Ackenheil, Manfred, et al.
Publicado: (2002)

Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
por: Marcus, Steven C., et al.
Publicado: (2008)

Neuroanatomical correlates of psychopathology in antipsychotic-naïve schizophrenia
por: Venkatasubramanian, Ganesan
Publicado: (2010)

The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia
por: McCabe, Rosemarie, et al.
Publicado: (2012)

Use of Conventional Antipsychotics and the Cost of Treating Schizophrenia
por: Lyu, Ramon R., et al.
Publicado: (2001)

Thalamic Shape Abnormalities in Antipsychotic Naïve Schizophrenia
por: Danivas, Vijay, et al.
Publicado: (2013)

Entorhinal Cortex Volume in Antipsychotic-naïve Schizophrenia
por: Jose, Sam P., et al.
Publicado: (2012)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka, Michal, et al.
Publicado: (2015)

Clinical predictors of therapeutic response to antipsychotics in schizophrenia
por: Carbon, Maren, et al.
Publicado: (2014)

Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia
por: Kakunje, Anil, et al.
Publicado: (2018)

Antipsychotics and risk of natural death in patients with schizophrenia
por: Chen, Yayun, et al.
Publicado: (2019)

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
por: Miyamoto, Seiya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ph1cv0sd6p66eldqmqpfek0nsj